ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) represents a distinct subtype characterized by the absence of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor type 2 (HER2) [1,2].